T2	KeyEntity 161 184;200 204	Tripeptidyl-peptidase I CLN2
T3	Entity 235 274	sedolisins (serine-carboxyl peptidases)
T5	Entity 334 365	fatal neurodegenerative disease
T6	Entity 377 422	late-infantile neuronal ceroid lipofuscinosis
T7	KeyEntity 682 686	CLN2
T8	Entity 1081 1110	Pseudomonas sp. 101 sedolisin
T9	Entity 999 1036	three-dimensional model of human CLN2
R3	participates_in Arg1:T8 Arg2:T9	
T10	KeyEntity 1125 1129	CLN2
T11	Entity 1138 1154	highly conserved
T12	Entity 1159 1177	widely distributed
T13	Entity 1380 1392	CLN2 enzymes
T14	Entity 1336 1363	almost completely conserved
T15	Entity 1434 1446	tripeptidase
T16	Entity 1649 1668	specific inhibitors
R4	participates_in Arg1:T10 Arg2:T11	
R5	participates_in Arg1:T10 Arg2:T12	
R6	participates_in Arg1:T13 Arg2:T14	
T17	KeyEntity 11 41	tripeptidyl-peptidase I (CLN2)
T18	Entity 45 55	ubiquitous
T19	Entity 60 76	highly conserved
T20	KeyEntity 91 107	sedolisin family
T21	KeyEntity 111 137	serine-carboxyl peptidases
T1	Entity 463 480	genomic sequences
T4	Entity 727 745	eukaryotic species
T22	Entity 783 795	80% identity
T23	Entity 830 837	macaque
T24	Entity 839 844	mouse
T25	Entity 846 849	rat
T26	Entity 851 854	dog
T27	Entity 860 863	cow
T28	Entity 932 953	fish (fugu and zebra)
T29	Entity 969 995	frogs (Xenopus tropicalis)
T30	KeyEntity 1717 1748	tripeptidyl-peptidase I (TPP-I)
T31	KeyEntity 1940 1945	TPP-I
T32	KeyEntity 2006 2010	CLN2
T33	KeyEntity 2104 2108	CLN2
T34	Entity 2063 2074;2082 2100	abolishment enzymatic activity
R2	participates_in Arg1:T34 Arg2:T33	
T35	Entity 2136 2177	fatal inherited neurodegenerative disease
T36	Entity 2179 2234	classical late-infantile neuronal ceroid lipofuscinosis
R7	is_subclass_of Arg1:T36 Arg2:T35	
R8	participates_in Arg1:T36 Arg2:T34	
T37	KeyEntity 2305 2309	CLN2
T38	Entity 2315 2331	serine peptidase
T39	KeyEntity 2454 2458	CLN2
T40	Entity 2536 2570	high-resolution crystal structures
#2	AnnotatorNotes T40	experimental_procedure
T41	KeyEntity 2634 2638	CLN2
T42	Entity 2640 2649	sedolisin
T43	Entity 2654 2665	kumamolisin
R9	participates_in Arg1:T42 Arg2:T40	
R10	participates_in Arg1:T43 Arg2:T40	
T44	Entity 2768 2794	serine-carboxyl peptidases
T45	Entity 2842 2889	fully conserved catalytic triad (Ser, Glu, Asp)
R11	is_part_of Arg1:T45 Arg2:T44	
T46	Entity 2916 2919	Asp
T47	Entity 2927 2940	oxyanion hole
R12	is_part_of Arg1:T46 Arg2:T47	
T48	Entity 2946 2955	Sedolisin
T49	Entity 2988 3034	kumamolisin, aorsin [9], and physarolisin [10]
T50	Entity 3059 3066	archaea
T51	Entity 3068 3076	bacteria
T52	Entity 3078 3083	fungi
T53	Entity 3088 3095	amoebae
T54	KeyEntity 3159 3163	CLN2
T55	Entity 3195 3205	sedolisins
R13	is_subclass_of Arg1:T2 Arg2:T3	
T56	Entity 1581 1605	physiological substrates
T57	Entity 1672 1676	CLN2
R14	interacts_with Arg1:T16 Arg2:T57	
T58	Entity 2754 2764	sedolisins
R1	is_part_of Arg1:T45 Arg2:T58	
T59	KeyEntity 3303 3307	CLN2
T60	Entity 3360 3380	genomic distribution
T61	Entity 3453 3468	crystallization
T62	Entity 3541 3556	crystallography
#1	AnnotatorNotes T62	experimental_test
T63	Entity 3560 3563	NMR
#3	AnnotatorNotes T63	experimental_test
T64	Entity 3603 3621	molecular modeling
T65	Entity 3770 3780	inhibitors
T66	Entity 3859 3871	HIV protease
T67	Entity 3902 3911	peptidase
T68	Entity 3919 3930	coronavirus
T69	Entity 3947 3980	severe acute respiratory syndrome
T70	Entity 4034 4061	molecular homology modeling
T71	KeyEntity 4091 4095	CLN2
T72	Entity 4147 4168	biological substrates
T73	Entity 4207 4236	design of specific inhibitors
#4	AnnotatorNotes T70	experimental_test
T74	KeyEntity 4291 4308	CLN2-like enzymes
T75	KeyEntity 4348 4352	CLN2
T76	Entity 4379 4389	sedolisins
R15	is_subclass_of Arg1:T75 Arg2:T76	
T77	Entity 4395 4421	highly conserved sequences
T78	Entity 4494 4506	195 residues
T79	Entity 4534 4544	maturation
T80	Entity 4559 4582	active catalytic domain
T81	KeyEntity 4621 4625	CLN2
T82	Entity 4756 4771	563 amino acids
T83	Entity 4786 4810	single polypeptide chain
R16	is_part_of Arg1:T82 Arg2:T83	
T84	Entity 4831 4841	prosegment
T85	Entity 4850 4866	catalytic domain
R17	is_part_of Arg1:T84 Arg2:T83	
R18	is_part_of Arg1:T85 Arg2:T83	
T86	KeyEntity 4890 4900	mouse CLN2
T87	Entity 4912 4927;4935 4945	single deletion prosegment
R19	is_part_of Arg1:T87 Arg2:T86	
T88	Entity 4959 4976;4998 5001	sequence identity 81%
T89	Entity 5015 5025;5029 5032	similarity 92%
T90	Entity 5094 5106	88% identity
T91	Entity 5111 5125	94% similarity
T92	Entity 5063 5068;5079 5086	human enzymes
T93	Entity 5073 5086	mouse enzymes
T94	Entity 5163 5177	78.5% identity
T95	Entity 5206 5227	mouse-human orthologs
T96	Entity 5240 5254	mammalian CLN2
T97	Entity 5271 5294	highly conserved enzyme
R20	is_part_of Arg1:T96 Arg2:T97	
T98	KeyEntity 5341 5358	CLN2-like enzymes
T99	Entity 5307 5327	Sequence comparisons
T100	Entity 5402 5409	enzymes
T101	Entity 5425 5435	prosegment
R21	is_part_of Arg1:T101 Arg2:T100	
T102	Entity 5458 5469	active site
T103	Entity 5566 5578	stability of
T104	Entity 5515 5533	conserved residues
T105	Entity 5625 5643	residues identical
T106	Entity 5717 5726	character
T107	Entity 5753 5778	maturation cleavage point
T108	Entity 5794 5804;5812 5825	N terminus active enzyme
T109	KeyEntity 5887 5904	CLN2-like enzymes
T110	Entity 5923 5927	fugu
T111	Entity 6023 6032	zebrafish
T112	Entity 6224 6242	zebrafish sequence
T113	KeyEntity 6280 6289	fugu CLN2
T114	Entity 6321 6329;6335 6352	deletion single nucleotide
T115	Entity 6391 6430	insertions of repeated nucleotide pairs
T116	Entity 6613 6629	global agreement
T117	Entity 6631 6645	69% identities
T118	Entity 6650 6666	83% similarities
T119	Entity 6690 6703	gene sequence
T120	KeyEntity 6711 6725	zebrafish CLN2
R22	participates_in Arg1:T119 Arg2:T120	
T121	Entity 6759 6777	manual corrections
T122	KeyEntity 6832 6843	fugu enzyme
T123	Entity 6845 6865	Inserted nucleotides
T124	Entity 6927 6946	amino acid sequence
T125	KeyEntity 6954 6970	fugu CLN2 analog
T126	KeyEntity 6984 6997	sedolisin-TPP
R23	is_part_of Arg1:T124 Arg2:T125	
T127	Entity 7055 7074	mammalian orthologs
T128	Entity 7120 7150	translated amino acid sequence
T129	Entity 7167 7176;7191 7198	mammalian enzymes
T130	Entity 7181 7198	zebrafish enzymes
T131	Entity 7209 7223	amino terminus
T132	Entity 7231 7248	propeptide region
T133	Entity 7268 7282	30 amino acids
R24	is_part_of Arg1:T131 Arg2:T132	
R25	is_part_of Arg1:T132 Arg2:T128	
T134	Entity 7417 7429	coding frame
T135	Entity 7454 7464	methionine
T136	Entity 7510 7531	full genomic sequence
T137	Entity 7551 7577	fugu sequencing consortium
T138	Entity 7608 7625	catalytic domains
T139	KeyEntity 7668 7672	CLN2
T140	Entity 7678 7683	human
T141	Entity 7685 7689	fugu
T142	Entity 7695 7704	zebrafish
T143	KeyEntity 7753 7757	CLN2
T144	KeyEntity 7629 7633	CLN2
R26	is_part_of Arg1:T138 Arg2:T144	
T145	Entity 7761 7779	Xenopus tropicalis
R27	is_part_of Arg1:T143 Arg2:T145	
T146	Entity 7812 7819	enzymes
T147	Entity 7877 7897	Active site residues
T148	KeyEntity 7926 7930	CLN2
T149	Entity 8001 8019	Xenopus tropicalis
T150	Entity 8067 8091	sedolisin-TPP (AL594774)
T151	Entity 8105 8117	EST database
T152	Entity 8129 8140;8148 8164	middle part catalytic domain
R28	is_part_of Arg1:T150 Arg2:T152	
T153	Entity 8199 8210	active site
T154	Entity 8225 8235	N terminus
T155	Entity 8254 8262;8276 8281	aspartic acids
T156	Entity 8267 8281	glutamic acids
T157	Entity 8301 8316	catalytic triad
R29	is_part_of Arg1:T155 Arg2:T157	
R30	is_part_of Arg1:T156 Arg2:T157	
T158	Entity 8366 8378	75% identity
T159	Entity 8388 8406	fugu sedolisin-TPP
T160	Entity 8412 8424	69% identity
T161	KeyEntity 8430 8440	human CLN2
T162	Entity 8476 8485;8496 8506	bacterial sedolisins
T163	Entity 8489 8506	fungal sedolisins
T164	Entity 8614 8628	CLN2 subfamily
T165	KeyEntity 8648 8682	highly conserved CLN2-like enzymes
T166	Entity 8719 8731	fish species
T167	Entity 8743 8748	frogs
T168	Entity 8773 8783	peptidases
T169	Entity 8815 8826	vertebrates
T170	Entity 8872 8878	humans
T171	Entity 8887 8891	mice
T172	KeyEntity 8960 8970	human CLN2
T173	KeyEntity 8998 9002	CLN2
T174	Entity 9011 9015;9021 9038	lack crystal structure
T175	Entity 9060 9076	protein modeling
T176	Entity 9127 9141	membrane-bound
T177	Entity 9117 9123	enzyme
R31	participates_in Arg1:T177 Arg2:T176	
T178	Entity 9152 9168	sequence 271–294
T179	Entity 9247 9267	transmembrane anchor
T180	Entity 9338 9368	fully water-soluble sedolisins
T181	KeyEntity 9447 9451	CLN2
T182	Entity 9453 9462	sedolisin
T183	Entity 9468 9479	kumamolisin
T184	Entity 9589 9611	homology-derived model
T185	KeyEntity 9615 9625	human CLN2
R32	other_relation Arg1:T184 Arg2:T185	
#5	AnnotatorNotes R32	model
T186	Entity 9652 9666	homology model
T187	Entity 9690 9710	complex of sedolisin
T188	Entity 9718 9744	covalently-bound inhibitor
T189	Entity 9746 9767	pseudo-iodotyrostatin
R33	interacts_with Arg1:T187 Arg2:T189	
T190	KeyEntity 9840 9850	human CLN2
T191	Entity 9883 9905	aldehyde functionality
T192	Entity 9916 9925	C-termini
R34	participates_in Arg1:T191 Arg2:T192	
T193	Entity 9953 9963;9980 9983	inhibitors Oda
T194	Entity 10022 10043	pseudo-iodotyrostatin
T195	Entity 10057 10066	inhibitor
T196	KeyEntity 10082 10086	CLN2
T197	Entity 10259 10288	pseudo-iodotyrostatin complex
T198	KeyEntity 10297 10301	CLN2
T199	Entity 10307 10319	tripeptidase
R35	is_part_of Arg1:T198 Arg2:T199	
T200	Entity 10335 10344	inhibitor
T201	Entity 10396 10413	tripeptide analog
T202	Entity 10423 10432	sedolisin
R36	interacts_with Arg1:T201 Arg2:T202	
T203	Entity 10445 10463	Sequence alignment
T204	Entity 10467 10476;10491 10498	bacterial enzymes
T205	Entity 10481 10498	mammalian enzymes
T206	Entity 10530 10539	sedolisin
T207	Entity 10541 10552	kumamolisin
T208	Entity 10558 10568	human CLN2
T209	Entity 10680 10696	r.m.s. deviation
T210	Entity 10723 10737	Cα coordinates
T211	KeyEntity 10754 10758	CLN2
T212	Entity 10804 10813	sedolisin
T213	Entity 10888 10897	sedolisin
T214	Entity 10902 10913	kumamolisin
T215	Entity 10934 10940;10952 10960	Cys327 residues
T216	Entity 10945 10960	Cys342 residues
T217	Entity 11020 11034	disulfide bond
T218	Entity 11178 11187;11192 11210	cysteines strictly conserved
T220	Entity 11242 11246	CLN2
R37	is_part_of Arg1:T218 Arg2:T220	
T219	Entity 11317 11337	bacterial sedolisins
T221	Entity 11353 11362	disulfide
T222	KeyEntity 11401 11405	CLN2
R38	is_part_of Arg1:T221 Arg2:T222	
T223	Entity 11478 11500	homology-derived model
T224	KeyEntity 11504 11514	human CLN2
T225	Entity 11538 11546	Cα trace
T226	KeyEntity 11550 11554	CLN2
T227	Entity 11516 11530	Ribbon diagram
T228	Entity 11605 11626;11630 11639	highly conserved core sedolisin
T229	Entity 11605 11626;11644 11655	highly conserved core kumamolisin
T230	Entity 11698 11709;11717 11725	Side chains residues
T231	Entity 11748 11755	mutated
R39	participates_in Arg1:T230 Arg2:T231	
T232	Entity 11798 11843	late-infantile neuronal ceroid lipofuscinosis
R40	is_part_of Arg1:T231 Arg2:T232	
T233	Entity 11863 11877	ball-and-stick
T234	Entity 11899 11924	substrate binding pockets
T235	KeyEntity 11928 11932	CLN2
T236	KeyEntity 11937 11946	sedolisin
T237	KeyEntity 11986 11990	CLN2
T238	Entity 12004 12016	tripeptidase
R41	is_part_of Arg1:T237 Arg2:T238	
T239	Entity 12044 12069	substrate-binding pockets
T240	Entity 12071 12073	S1
T241	Entity 12082 12084	S3
T242	Entity 12172 12177	P1-P3
T243	Entity 12185 12194	inhibitor
R42	is_part_of Arg1:T242 Arg2:T243	
T244	Entity 12307 12316	sedolisin
T245	Entity 12320 12331	kumamolisin
T246	Entity 12337 12347	inhibitors
T247	Entity 12365 12373	tyrosine
T248	Entity 12379 12392	phenylalanine
T249	Entity 12407 12416	S1 pocket
R43	interacts_with Arg1:T248 Arg2:T249	
R44	interacts_with Arg1:T247 Arg2:T249	
T250	Entity 12443 12458	fully conserved
T251	Entity 12475 12485	sedolisins
T252	Entity 12525 12540;12548 12554	right-hand side pocket
T253	Entity 12601 12611	main chain
T254	Entity 12622 12638	residues 164–165
T255	KeyEntity 12719 12729	human CLN2
T256	Entity 12749 12759	main chain
T257	Entity 12787 12814	hydrogen-bonded interaction
T258	Entity 12824 12844	side chain of Thr279
R45	interacts_with Arg1:T257 Arg2:T256	
R46	is_part_of Arg1:T258 Arg2:T257	
T259	Entity 12858 12883	signature sequence SGTSAS
T260	Entity 12900 12916	catalytic Ser280
T261	Entity 12959 12965	Asp165
T262	Entity 12981 12990	conserved
T263	Entity 13023 13029;13037 13050	lining oxyanion hole
T264	Entity 13102 13111	S1 pocket
T265	Entity 13139 13150	side chains
T266	Entity 13237 13251	steric barrier
T267	Entity 13256 13273	excluding solvent
T268	Entity 13334 13350	residues 130–132
T269	Entity 13320 13330	main chain
T270	Entity 13366 13382	conserved Gly131
T271	Entity 13466 13476	P1 residue
T272	Entity 13484 13493	substrate
R47	is_part_of Arg1:T271 Arg2:T272	
R48	is_part_of Arg1:T269 Arg2:T268	
